Pharmacologic targeting of Cdc42 GTPase by a small molecule Cdc42 activity-specific inhibitor prevents platelet activation and thrombosis
Open Access
- 23 June 2021
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-13
Abstract
Gene targeting of Cdc42 GTPase has been shown to inhibit platelet activation. In this study, we investigated a hypothesis that inhibition of Cdc42 activity by CASIN, a small molecule Cdc42 Activity-Specific INhibitor, may down regulate platelet activation and thrombus formation. We investigated the effects of CASIN on platelet activation in vitro and thrombosis in vivo. In human platelets, CASIN, but not its inactive analog Pirl7, blocked collagen induced activation of Cdc42 and inhibited phosphorylation of its downstream effector, PAK1/2. Moreover, addition of CASIN to washed human platelets inhibited platelet spreading on immobilized fibrinogen. Treatment of human platelets with CASIN inhibited collagen or thrombin induced: (a) ATP secretion and platelet aggregation; and (b) phosphorylation of Akt, ERK and p38-MAPK. Pre-incubation of platelets with Pirl7, an inactive analog of CASIN, failed to inhibit collagen induced aggregation. Washing of human platelets after incubation with CASIN eliminated its inhibitory effect on collagen induced aggregation. Intraperitoneal administration of CASIN to wild type mice inhibited ex vivo aggregation induced by collagen but did not affect the murine tail bleeding times. CASIN administration, prior to laser-induced injury in murine cremaster muscle arterioles, resulted in formation of smaller and unstable thrombi compared to control mice without CASIN treatment. These data suggest that pharmacologic targeting of Cdc42 by specific and reversible inhibitors may lead to the discovery of novel antithrombotic agents.Keywords
Funding Information
- Higher Education Commision, Pakistan (post-doctoral fellowship)
- National Institutes of Health Office of Dietary Supplement
- National Institutes of Health (R01 CA204895)
- American Heart Association
This publication has 54 references indexed in Scilit:
- Antithrombotic Drugs and Their Complications2014
- The PAK system links Rho GTPase signaling to thrombin-mediated platelet activationAmerican Journal of Physiology-Cell Physiology, 2013
- Rho GTPases in platelet functionJournal of Thrombosis and Haemostasis, 2012
- Gene Targeting Implicates Cdc42 GTPase in GPVI and Non-GPVI Mediated Platelet Filopodia Formation, Secretion and AggregationPLOS ONE, 2011
- Platelet adhesion and activation mechanisms in arterial thrombosis and ischaemic strokeJournal of Thrombosis and Haemostasis, 2011
- Signaling During Platelet Adhesion and ActivationArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Multiple alterations of platelet functions dominated by increased secretion in mice lacking Cdc42 in plateletsBlood, 2010
- Genetic and pharmacologic evidence that Rac1 GTPase is involved in regulation of platelet secretion and aggregationJournal of Thrombosis and Haemostasis, 2007
- Activation of Platelet Function Through G Protein–Coupled ReceptorsCirculation Research, 2006
- Rac1 Is Essential for Platelet Lamellipodia Formation and Aggregate Stability under FlowJournal of Biological Chemistry, 2005